ED TRIAL PACK

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: SILDENAFIL CITRATE
FORM: 100 PILLS x 50 MG
ACTIVE HALF-LIFE: 3-4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: SILDENAFIL CITRATE
FORM: 100 PILLS x 100 MG
ACTIVE HALF-LIFE: 3-4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CIPLA

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 50 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CIPLA

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCES:
- 60 MG DAPOXETINE
- 100 MG SILDENAFIL CITRATE
MIXED FORM: 16 PILLS x 160 MG
ACTIVE HALF-LIFE: 3-4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AJANTA PHARMA

CLASSIFICATION: ERECTILE DYSFUNCTION (PDE5 INHIBITOR)
ACTIVE SUBSTANCE: VARDENAFIL
FORM: 4 PILLS x 10 MG
ACTIVE HALF-LIFE: 4-5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: BAYER SCHERING

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: SILDENAFIL CITRATE
FORM: 120 PILLS x 280 MG
ACTIVE HALF-LIFE: 3-4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC